Completed PHASE1 INTERVENTIONAL 2-arm NCT04082962

Dexamethasone Implant for Retinal Detachment in Uveal Melanoma

Dexamethasone Intravitreal Implant for the Management of Exudative Retinal Detachment in Patients With Uveal Melanoma

Sponsor: Ivana K. Kim

Conditions Exudative Retinal Detachment and Uveal Melanoma

Interventions Dexamethasone intravitreal implant

Updated 8 times since 2019 Last updated: Dec 9, 2025 Started: Dec 11, 2018 Primary completion: Dec 7, 2023 Completion: Dec 7, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Exudative Retinal Detachment and Uveal Melanoma, this trial is completed. The trial is conducted by Ivana K. Kim and has accumulated 8 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE1

Status: Unknown → Completed
Sep 2024 — Jan 2026 [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Aug 2023 — Jul 2024 [monthly]

Unknown Status PHASE1

Status: Recruiting → Unknown Status
Sep 2021 — Aug 2023 [monthly]

Recruiting PHASE1

▶ Show 3 earlier versions

Jan 2021 — Sep 2021 [monthly]

Recruiting PHASE1
Mar 2020 — Jan 2021 [monthly]

Recruiting PHASE1
Oct 2019 — Mar 2020 [monthly]

Recruiting PHASE1

First recorded

Dec 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ivana K. Kim

Data source: Massachusetts Eye and Ear Infirmary

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States